MA33882B1 - Nouveaux derives azabicyclo [3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents

Nouveaux derives azabicyclo [3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Info

Publication number
MA33882B1
MA33882B1 MA34932A MA34932A MA33882B1 MA 33882 B1 MA33882 B1 MA 33882B1 MA 34932 A MA34932 A MA 34932A MA 34932 A MA34932 A MA 34932A MA 33882 B1 MA33882 B1 MA 33882B1
Authority
MA
Morocco
Prior art keywords
azabycyclo
hex
pharmaceutical compositions
compositions containing
new derivatives
Prior art date
Application number
MA34932A
Other languages
Arabic (ar)
English (en)
French (fr)
Inventor
Patrick Gasara
Anne-Marie Chollet
Alain Dhainaut
Jean-Michel Henlin
Pierre Lestage
Fany Panayi
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42711699&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA33882(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of MA33882B1 publication Critical patent/MA33882B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA34932A 2009-12-09 2010-12-08 Nouveaux derives azabicyclo [3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent MA33882B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0905953A FR2953521B1 (fr) 2009-12-09 2009-12-09 Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2010/000823 WO2011070253A1 (fr) 2009-12-09 2010-12-08 Derives azabicyclo [3.1.0] hex- 2 -yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
MA33882B1 true MA33882B1 (fr) 2013-01-02

Family

ID=42711699

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34932A MA33882B1 (fr) 2009-12-09 2010-12-08 Nouveaux derives azabicyclo [3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Country Status (32)

Country Link
US (1) US20120283245A1 (enrdf_load_stackoverflow)
EP (1) EP2509947A1 (enrdf_load_stackoverflow)
JP (1) JP2013513589A (enrdf_load_stackoverflow)
KR (1) KR20120102763A (enrdf_load_stackoverflow)
CN (1) CN102652127A (enrdf_load_stackoverflow)
AP (1) AP2012006352A0 (enrdf_load_stackoverflow)
AR (1) AR079265A1 (enrdf_load_stackoverflow)
AU (1) AU2010329762B2 (enrdf_load_stackoverflow)
BR (1) BR112012013666A2 (enrdf_load_stackoverflow)
CA (1) CA2782469C (enrdf_load_stackoverflow)
CL (1) CL2012001479A1 (enrdf_load_stackoverflow)
CO (1) CO6541535A2 (enrdf_load_stackoverflow)
CR (1) CR20120286A (enrdf_load_stackoverflow)
CU (1) CU20120091A7 (enrdf_load_stackoverflow)
EA (1) EA201200849A1 (enrdf_load_stackoverflow)
EC (1) ECSP12011950A (enrdf_load_stackoverflow)
FR (1) FR2953521B1 (enrdf_load_stackoverflow)
GE (1) GEP20156227B (enrdf_load_stackoverflow)
IN (1) IN2012DN04966A (enrdf_load_stackoverflow)
MA (1) MA33882B1 (enrdf_load_stackoverflow)
MX (1) MX2012006578A (enrdf_load_stackoverflow)
NI (1) NI201200099A (enrdf_load_stackoverflow)
PE (1) PE20121475A1 (enrdf_load_stackoverflow)
PH (1) PH12012501053A1 (enrdf_load_stackoverflow)
SA (1) SA110320011B1 (enrdf_load_stackoverflow)
SG (1) SG181082A1 (enrdf_load_stackoverflow)
TN (1) TN2012000267A1 (enrdf_load_stackoverflow)
TW (1) TW201200499A (enrdf_load_stackoverflow)
UA (1) UA102950C2 (enrdf_load_stackoverflow)
UY (1) UY33072A (enrdf_load_stackoverflow)
WO (1) WO2011070253A1 (enrdf_load_stackoverflow)
ZA (1) ZA201203943B (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015032966A1 (en) * 2013-09-09 2015-03-12 Sanofi An h3 receptor antagonist combined with a cholinesterase inhibitor for use in the treatment of alzheimer's disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2866647B1 (fr) * 2004-02-20 2006-10-27 Servier Lab Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB0507680D0 (en) * 2005-04-15 2005-05-25 Glaxo Group Ltd Compounds
ATE466007T1 (de) * 2005-11-30 2010-05-15 Hoffmann La Roche 5-substituierte indol-2-carbonsäureamidderivate

Also Published As

Publication number Publication date
UA102950C2 (ru) 2013-08-27
BR112012013666A2 (pt) 2016-04-19
SA110320011B1 (ar) 2013-10-01
US20120283245A1 (en) 2012-11-08
AU2010329762B2 (en) 2013-10-03
ZA201203943B (en) 2013-08-28
WO2011070253A8 (fr) 2012-08-02
CU20120091A7 (es) 2012-07-31
CA2782469C (fr) 2014-04-08
FR2953521B1 (fr) 2011-11-18
IN2012DN04966A (enrdf_load_stackoverflow) 2015-09-25
FR2953521A1 (fr) 2011-06-10
CL2012001479A1 (es) 2013-02-08
PH12012501053A1 (en) 2013-02-04
AR079265A1 (es) 2012-01-04
CA2782469A1 (fr) 2011-06-16
MX2012006578A (es) 2012-06-25
JP2013513589A (ja) 2013-04-22
EA201200849A1 (ru) 2013-01-30
KR20120102763A (ko) 2012-09-18
CN102652127A (zh) 2012-08-29
EP2509947A1 (fr) 2012-10-17
SG181082A1 (en) 2012-07-30
WO2011070253A1 (fr) 2011-06-16
PE20121475A1 (es) 2012-10-20
CO6541535A2 (es) 2012-10-16
AP2012006352A0 (en) 2012-08-31
CR20120286A (es) 2012-08-20
NI201200099A (es) 2012-11-09
TW201200499A (en) 2012-01-01
AU2010329762A1 (en) 2012-06-21
ECSP12011950A (es) 2012-07-31
UY33072A (es) 2011-05-31
GEP20156227B (en) 2015-01-26
TN2012000267A1 (fr) 2013-12-12

Similar Documents

Publication Publication Date Title
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
EA201170772A1 (ru) Органические соединения
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
MY151986A (en) Adamantyl diamide derivatives and uses of same
ECSP066376A (es) FORMA CRISTALINA GAMMA-d DEL CLORHIDRATO DE IVABRADINA, SU PROCEDIMIENTO DE PREPARACIÓN Y COMPOSICIONES FARMACÉUTICAS QUE LA CONTIENEN
MX2010008051A (es) Nuevos derivados de fluoroglicosidos aromaticos, productos farmaceuticos que comprenden dichos compuestos y uso de los mismos.
CY1111367T1 (el) Νεα παραγωγα της διοσμετινης, η μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα περιεχουν
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
CY1109637T1 (el) Νεα τρικυκλικα παραγωγα, η μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα περιεχουν
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
EA201001087A1 (ru) Новые дигидроиндолоновые соединения, способ их получения и фармацевтические композиции, содержащие их
EA201291014A1 (ru) Трициклическое индазольное соединение, способ его получения и содержащая его фармацевтическая композиция
TN2012000105A1 (en) Spirolactam derivatives and uses of same
EA200801137A1 (ru) Соединения для ингибирования апоптоза
EA200701178A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
MA33882B1 (fr) Nouveaux derives azabicyclo [3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MX2012005596A (es) Derivados de difenil azepano como inhibidores de reabsorcion de monoaminas.
NO20083352L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
EA200701177A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
UA91646C2 (ru) Соединения индола, способ их получения и фармацевтическая композиция (варианты), которая их содержит
EA200900692A1 (ru) Новые азабициклические соединения, способ их получения и фармацевтические композиции, которые их содержат
EA200702590A1 (ru) Ингибиторы растворимой аденилатциклазы
ATE522530T1 (de) 2-piperazin-1-yl-3h-imidazoä4,5-bü- pyridinderivate